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ABSTRACT
Objective: An effort was made to design and synthesize the series of sulfadiazine building blocks as a targeted candidate for antimycobacterial activity.
Method: The synthesized compounds were subjected to preliminary in silico screening study for testing their antimycobacterial action by doing their 
molecular docking study on bioinformatics software, molecular operating environment 2009.10.
Result: The results obtained from this tool showed that there is a best docking affinity score of these target compounds against the enzyme InhA 
Enoyl-(acyl-carrier-protein) reductase from Mycobacterium tuberculosis (MTB) pathogen, which is one of the key enzymes involved in the type II fatty 
acid biosynthesis pathway of MTB.
Conclusion: Thus, the synthesized sulfadiazine Schiff base derivatives might serve as the best drug candidate for the existence of menacing pathogen 
MTB.
Keywords: Antimycobacterial activity, Sulfadiazine Schiff base, Molecular docking study.
INTRODUCTION
Tuberculosis (TB), which is an airborne infectious disease caused 
predominantly by Mycobacterium tuberculosis (MTB), is a global health 
problem and a leading cause of death among adults in the developing 
country. At present among the 8 million TB infected individual, around 
2 million people will die due to this active TB. To defeat this situation, 
now a day there are several treatment techniques has been followed to 
fight this TB. Besides the antibiotic treatment is one of the best methods 
to fight this TB condition [1-3]. Owing to the complicated shape and 
cell wall constituents of the mycobacterium, this will make the many 
antibiotics into ineffective and hinders the entry of drugs. Multidrug 
resistance TB [4] is a serious threat to TB control and prevention. The 
emergence of multidrug resistance has forced to the development of 
new class of therapeutic agents. Therefore, there is an interest in search 
of alternative antibiotics used as anti- TB agents. Among such agents, 
sulfonamides are structural analogs of para-aminobenzoic acid (PABA), 
inhibiting competitively the dihydropteroate synthase and blocking 
the folic acid synthesis pathway and cell division [5-7]. The most of the 
compounds having sulfonamide moiety in its structure may have the 
antibacterial [8,9], carbonic anhydrase inhibitor [10], antiviral [11], 
antifungal [12], anti-inflammatory activities [13,14], antitumor [15], 
and antithyroid activity [16,17]. Schiff base of sulfonamides entity has 
also been shown to exhibit an antifungal, antibacterial, antimalarial, 
antiproliferative, anti-inflammatory, antiviral, and antipyretic 
properties [18]. Sulfadiazine is one of the sulfanilamide derivatives that 
are used as an antibacterial as well as an antimalarial drug and thought 
to act as PABA competitive inhibitor [19]. Moreover, it possesses SO2NH 
moiety as an important group for their antimycobacterial activity. Based 
on these facts, new Schiff base derivatives tagged with sulfadiazine 
moiety were proposed and presented in this article.
Due to the global impact of this overwhelming disease, several different 
strategies such as targeting bacterial virulence, high-throughput 
screening, structure-based drug discovery, chemical modifications of 
the known drugs, and combinatorial chemistry have been explored to 
search for novel biologically important molecules [20]. Computer-based 
(in silico) molecular modeling (bioinformatics and cheminformatics) is 
quite useful for this purpose because they are extremely fast and cost-
efficient and can be applied even when a compound is not physically 
available.
Keeping this point discussed in above paragraph, and based on 
previously reported research work [21], we have decided to combine 
the two pharmacophores for testing their antimycobacterial activity, 
namely, sulfadiazine with an aromatic aldehyde into one molecule, 
i.e., Schiff base entity. Many kinds of literature revealed that the 
Schiff bases are the key intermediates for the synthesis of numerous 
bioactive medicinal compounds from the primary amine [22]. In recent 
years, the chemistry of Schiff bases contains N-donor atom which has 
been extensively studied and has acquired a great interest because 
of the azomethine RHC=N-R1 linkage, where R and R1 are alkyl, aryl, 
cycloalkyl, or heterocyclic groups which is essential for its biological 
activity [23,24]. Before stepping into its pharmacological evaluation 
on MTB, we have decided to go for their in silico docking study using 
Molecular Operating Environment (MOE) 2009.10 software for its 
affinity toward the receptor protein enoyl-acyl carrier protein (ACP) 
reductase, which is isolated from MTB pathogen.
METHODS
All the chemicals in this synthesis were of AR and LR grade and were 
obtained from Merck, Hi-Media, and Sigma-Aldrich, SD Fine chem., Mumbai. 
All the chemicals were used as received without further purification.
Experimental section
Melting points were determined in open capillaries on a Thomas 
Hoover apparatus and are uncorrected. The synthesized compounds 
were characterized by the following methods: IR spectra of synthesized 
compounds were recorded on Shimadzu (8300, Kyoto, Japan) and 
Fourier-transform infrared spectrophotometer in the range of 
4000 cm−1–400 cm−1 using KBr pellet technique. Proton nuclear 
magnetic resonance (NMR) spectra were recorded using BRUKER 
300 MHz NMR Spectrometer using the solvent deuterated chloroform. 
Chemical shifts (d) were recorded in parts per million (ppm) and 
trimethylsilane used as an internal standard.
© 2018 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
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General procedure for the synthesis of sulfadiazine Schiff base 
analogs (S1-S9)
An equimolar quantity of sulfadiazine (0.1 M) and aromatic aldehyde 
(0.1 M) was dissolved in 15 ml of ethanol and then added a catalytic 
amount of glacial acetic acid into it and refluxed for 6–8 h, and the 
reaction time may depend on the aldehyde which we used for this 
synthesis. Completion of the reaction was confirmed by thin-layer 
chromatography. The reaction mixture was then poured into ice-cold 
water, and the obtained precipitate was filtered and dried. The product 
was recrystallized from absolute ethanol. The reaction sequences for 
synthesized compounds leading to the formation of new compounds 
are outlined in Fig. 1.











In modern drug designing scenario, the molecular docking is commonly 
used for the understanding of target-receptor binding interaction and 
is quite often used to predict the binding orientation of target molecule 
of the lead with their protein receptor to find the affinity of that target 
compound [25]. Keeping this in mind, we undertook to design novel 
antimycobacterial candidates, which will target promisingly with the 
enzymes involved in the biosynthesis of microbial cell wall. To rationalize 
the biological results of our compounds, an in silico molecular docking 
studies with the enoyl-ACP reductase (InhA) of MTB were carried out to 
determine the best conformation. Enoyl-ACP reductase (ENR) is a key 
enzyme of the type II fatty acid synthesis system [26].
Software used
The designed structures of nine sulfadiazine Schiff base derivatives were 
generated using Marvin_Windows-x64_18.8 version. Marvin Sketch 
is an advanced chemical tool for illustrating the chemical structures, 
queries, reactions, etc. [27]. Then, the structures were viewed on Marvin 
Viewer screen to generate the SMILES notation and to IUPAC name of the 
synthesized compounds. The target ligand files for the molecular docking 
studies were built on MOE 2009.10 by Chemical Computing Group (https://
www.chemcomp.com/MOE-Molecular_Operating_Environment.htm).
Preparation of target ligand files
The molecular geometries were drawn and correct 3D structures 
were ensured and were followed by energy optimization at a standard 
MMFF94 force field level, with a 0.0001 kcal/mol energy gradient 
convergence criterion [28]. The molecule builder of MOE program was 
used for this purpose , and after building the molecule, it was energy 
minimized, potential energy and partial energy were corrected, and 
then, it was saved as molecular database (mdb) file in a local directory 
for the further process.
Preparation of receptor
The crystal 3D structure of enzyme enoyl-ACP reductase (Protein Data 
Bank file: 2NSD) was obtained from Protein Data Bank (http://www. 
rcsb.org/pdb). The pdb file was imported to MOE suite where receptor 
preparation module was used to prepare the protein. All the bound 
water molecules and hetero atom were removed from the complex 
using sequence (SEQ) window which is default in MOE program. Both 
polar and non-polar hydrogens were added and 3D structure was 
corrected. The 3-D protonated structure was energy minimized. Since 
the protein was devoid of associated ligand, the pocket was identified 
using the active site finder module of the MOE. To visualize the binding 
pocket, alpha spheres were created followed by the generation of 
dummy atoms on the centers of these spheres. The pockets were found 
to be deep small canyons lined with the key residues including both 
hydrophobic and hydrophilic amino acids.
Docking methodology
The optimized target ligands were docked with the enzymes enoyl-ACP 
reductase (PDB: 2NSD) protein using the MOE, 2009.10. For docking 
Fig. 1: Schematic representation for the synthesis of sulfadiazine 
Schiff base
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simulations, the placement was set as triangular matcher, rescoring 
was set as London dG, the number of retaining was set as 10, and the 
refinement was set as force field on MOE suite to generate 10 poses of 
each target ligand confirmations. As a result of docking run, the mdb. 
output files were created with scoring and multiple conformations 
of each compound. All the docked conformations were analyzed, and 
the best-scored pose for each compound was selected for further 
interaction studies. Besides, the ligand-receptor interaction followed 
by surface analysis of the selected best pose ligand molecule was 
generated on MOE suite and viewed for interpretation.
RESULT AND DISCUSSION
The new series of sulfadiazine aldehyde Schiff base derivatives were 
synthesized and evaluated for their in silico antimycobacterial activity. 
The synthesized compounds were obtained in reasonable yield. The 
percentage yield and melting point of the synthesized compounds were 
recorded and presented uncorrected. IR and 1H NMR spectral data of 
synthesized compounds were given below.
S1: 4-[(E)-{4-(dimethyl amino)phenyl]methylidene}amino]-N-
(pyrimidin-2-yl)benzene-1-sulfonamide. Yellowish-orange solid; 
yield - 90%; m.p - 240–260○C. IR γ (cm−1) (KBr): 3266 cm−1(N-H str); 
3075 cm−1(C-H Ar str); 1569 cm−1 (HC=N); 1520 cm−1 (C=C Ar).1H NMR 
δ ppm (TMS): 8.43(1H, S, CH=N), 8.60-6.81 (m, 12H, Ar-H), 3.08 (m, 
methyl)
S2: -4-{(E)-[(oxolan-2-yl) methylidene]amino}-N-(Pyrimidin-2yl)
benzene-1-sulfonamide. Brown solid; yield-82%; m.p - 270–276○C. IR 
γ (cm−1) (KBr): 2978 cm−1 (C-H Ar str); 3280 cm−1 (N-H str); 1633 cm−1 
(HC=N); 1578 cm−1 (C=C Ar).1H NMR δ ppm (TMS): 8.46(1H, S, CH=N), 
8.45-6.93 (m, 11H, Ar-H).
S3: 4-{(E)-[(4-Hydroxy-3-methoxy Phenyl)methylidene]amino}-N-
(pyrimidin-2-yl)benzene-1-sulfonamide. Yellow solid; m.p - 224○C; 
yield - 81%. IR γ (cm−1) (KBr): 3070 cm−1 (C-H Ar str); 3589 cm−1 (O-H); 
3224 cm−1 (N-H str); 1620 cm−1 (HC=N); 2807 cm−1 (C-H Ar str).1H NMR 
δ ppm (TMS): 8.89 (1H, S, CH=N), 8.51-7.47 (m, 11H, Ar-H).
S4: 4-{(E)-[(2-chlorophenyl)methylidene]amino}-N-(Pyrimidin-2yl)
benzene-1-sulfonamide. Slight yellowish solid; m.p - 200–210○C; 
yield - 77%. IR γ (cm−1) (KBr): 3020 cm−1 (C-H Ar str); 3289 cm−1 (N-H 
str); 1620 cm−1 (HC=N); 1582 cm−1 (C=C Ar str).1H NMR δ ppm (TMS): 
8.67 (1H, S, CH=N), 8.41-7.40 (m, 12H, Ar-H).
S5: 4-{(E)-[(4-chlorophenyl)methylidine]amino}-N-(Pyrimidin-2yl)
benzene-1-sulfonamide.light yellowish solid; yield - 75%; m.p - 220–
240○C. IR γ (cm−1) (KBr): 3020 cm−1 (C-H Ar str); 3289 cm−1 (N-H str); 
1620 cm−1 (HC=N); 1582 cm−1 (C=C Ar str).1H NMR δ ppm (TMS): 
8.66 (1H, S, CH=N), 8.45-7.52 (m, 12H, Ar-H).
S6: 4-{(E)-[(C4-methoxy phenyl)methylidene]amino}-N-(Pyrimidin-
2-yl-) benzene-1-sulfonamide. light yellowish solid; yield - 70%; 
m.p - 220–240○C. IR γ (cm−1) (KBr): 2972 cm−1 (C-H Ar str); 3272 cm−1 
(N-H str); 1610 cm−1 (HC=N); 1572 cm−1 (C=C Ar str).1H NMR δ ppm 
(TMS): 8.60 (1H, S, CH=N), 7.90-7.08 (m, 12H, Ar-H), 3.82 (s, 3H, OCH3).
S7: 4-[(E)-benzylidene amino]-N-(Pyrimidin-2-yl) benzene-1-
Sulfonamide. Yellowish white solid; yield - 80%; m.p - 200–210○C. IR 
γ (cm−1) (KBr): 3002 cm−1 (C-H Ar str); 3290 cm−1 (N-H str); 1615 cm−1 
(HC=N); 1584 cm−1 (C=C Ar str).1H NMR δ ppm (TMS): 8.65 (1H, S, 
CH=N), 8.00-7.42 (m, 12H, Ar-H) 7.52-7.82 (Ar benzene).
S8: 4- [(E)-[(2E)-3-phenylprop-2-en-1-ylidene] amino]-N- (pyrimidin-2-
yl) benzene-1-sulfonamide. Yellowish solid; yield - 70%; m.p - 215–
210○C. IR γ (cm−1) (KBr): 3072 cm−1 (C-H Ar str); 3285 cm−1 (N-H str); 
1631 cm−1 (HC=N); 1735 cm−1 (C=C Ar str).1H NMR δ ppm (TMS): 
7.48 (1H, S, CH=N), 8.45-6.79 (m, 13H, Ar-H)., 6.80-7.22 (s, 2H, C=C)
S9: 4-{(E)-[(2-nitrophenyl)methylidene]amino}-N-(pyrimidin-2-yl)
benzene-1-sulfonamide, Brown solid, yield - 70%, m.p - 260–270○C. IR 
γ (cm−1) (KBr): 3045 cm−1 (C-H Ar str); 3290 cm−1 (N-H str); 1650 cm−1 
(HC=N).1H NMR δ ppm (TMS): 9.07 (1H, S, CH=N), 8.69-7.29 (m, 11 H, 
Ar-H).
Result on molecular docking studies of target molecules
All the docked conformations for each compound were analyzed and 
it was found that the most favorable docking poses with a maximum 
number of interactions were those which were ranked the highest 
score based on the minimal binding energy, which was computed as a 
negative value by the MOE software. Then considering the root mean 
square deviation (RMSD) value, generally, acceptable range of the RMSD 
when the model is overlapped to the template is 2 Å. For protein-ligand 
docking, 2 Å is good, and 1 Å and less is great. However, this RMSD 
value may not be considered as the only criteria for evaluation of the 
model constructed. Some deviations at times can be considered. Based 
on this declaration, in this present report, the compounds showed that 
the RMSD value ranges between 1.0577 and 2.8925, and this result 
suggests that the synthesized compounds showed a good RMSD value.
The MOE software generated docking score of the all the molecules is 
summarized in Table 1. The most favorable docking poses of the 10 
docked conformations for each molecule were analyzed for further 
investigation of the ligand interactions within the active sites. The 
wonderful number of interactions with active site residues coupled 
with favorable binding energy states that these target molecules may 
serve as an effective replacement agent for the antimycobacterial drugs. 
These ligands showed a proper binding pattern and anchored tightly 
inside the active site canyon (Site I) of the protein. The 2D ligand-
protein interactions were visualized using the MOE ligand interaction 
program for all the molecules as shown in Figs. 2-4.
The best docking poses of almost all the nine designed molecules were 
formed a single cluster inside the active site cleft of the receptor. Among 
these nine designed molecules, the best three molecules are S3, S5, and S8 
ligand and they showed the best interaction within the receptor as shown 
in Figs. 2-4. The calculated surface analysis pocket for these molecules 
Table 1: Docking results for sulfadiazine derivatives with protein PDB: 2NSD
Molecule code S rmsd_refine E_conf E_place E_score1 E_refine No. of conf.
S1 −27.3491 2.0017 −125.3771 −83.8810 −10.3766 −27.3491 9
S2 −24.0552 1.0577 −130.1177 −81.0930 −9.9884 −24.0552 10
S3 −28.3494 1.7535 −117.2406 −76.6933 −12.0955 −28.3494 10
S4 −25.5142 2.0828 −123.9907 −80.1463 −10.2673 −25.5142 10
S5 −27.2418 1.5564 −123.5227 −72.1410 −10.8508 −27.2418 10
S6 −24.0687 2.7787 −115.3049 −68.6075 −10.7929 −24.0687 10
S7 −26.0306 2.8925 −122.4127 −83.4326 −10.9632 −26.0306 8
S8 −28.0579 1.5476 −133.8988 −108.2688 −10.6365 −28.0579 10
S9 −21.1248 1.5650 −112.9345 −82.3756 −10.7156 −21.1248 9
S: The final score, rmsd_refine: The root mean squar deviation between the pose before refinement and the pose after refinement, E_conf: The energy of the 
conformer. E_place: Score from the placement stage, E_score1: Score from the rescoring stage (s), E_refine: Score from the refinement stage, and No. of conf: number of 
conformations generated by ligand, PDB: Protein data bank
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was shown in Figs. 2-4. The molecules under consideration for further 
synthesis have a higher binding affinity with the receptors, in All the 
synthesized compounds have a higher binding affinity with the receptors 
(Protein ID: 2NSD) in the binding energy range of −28.3494 to −21.1248 
kcal/mol and the range of London dG is −10.9632 to −09.9884 kcal/mol.
Docking analysis reveals that the molecule S3 interacted with receptor 
through backbone acceptor with Gly 14 and side chain donor with Ser 20 
(Fig. 2). The number of conformations generated by molecule S3 was 10 
which indicated that flexibility is an important parameter for the ligand 
to dock deeply within the binding pocket of enoyl acyl reductase enzyme. 
The lowest docking score for molecule S3 was −28.3494, which indicates 
that compound is active at this energy of conformation. Further, a careful 
calculation of surface analysis of the binding pocket of this molecule 
indicated that molecule S3 adopted a position in a hydrophobic cage 
surrounded by the following amino acids residue such as Tyr 158, Ile 
16, Thr 196, Met 199, Pro 193, Phe 149, Ala 198, Gly 14, and Ser 20 and 
these were approach closely to the ligand for strong interactions.
Docking analysis reveals that the molecule S5 interacted with receptor 
through backbone donor with Ser 94 and side chain acceptor with Ser 
94 and Ser 20 which is shown in Fig. 3. The number of conformations 
generated by molecule S5 was 10, and the lowest docking score for 
molecule S5 was −27.2418. The calculation of surface analysis showed 
the binding pocket of this molecule indicating that this molecule S5 
adopted a position in a hydrophobic cage surrounded by the following 
Fig. 2: (a and b) Ligand Receptor interaction and binding surface of compound S3 with 2NSD
ba
Fig. 3: (a and b) Ligand receptor interaction and binding surface of compound S5 with 2NSD
ba
Fig. 4 (a-b): Ligand Receptor interaction and binding surface of compound S8 with 2NSD 
ba
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amino acids residue such as Gly 14, Gly 96, Ala 22, Thr 196, Phe 149, Tyr 
158, Ile 21, Ser 94, and Ser 20 for its strong interactions.
Docking analysis reveals that the molecule S8 interacted with receptor 
through backbone acceptor with Ser 94 and side chain donor with Ser 
94 and Ser 20 which is shown in Fig. 4. The number of conformations 
generated by molecule S8 was 10 which indicates The total of 10 
conformations was generated by a compound S8, which indicates 
that the flexibility of interaction of the ligand with the protein binding 
pocket of enoyl-acyl reductase enzyme. The lowest docking score for 
molecule S8 was −28.0579. The calculation of surface analysis showed 
the binding pocket of this molecule indicating that this molecule S8 
adopted a position in a hydrophobic cage surrounded by the following 
amino acids residue such as Gly 14, Gly 96, Thr 96, Ala 22, Tyr 158, Ile 
21, Met 199, Ser 94, and Ser 20 for its strong interactions.
CONCLUSION
In-silico docking study of the target molecules (ligand) with enoyl-ACP 
reductase (receptor) were run; the results showed that the best docking 
score was obtained for the target molecules S3, S5, and, S8 among this 
nine designed molecules. Therefore, this effect is due to the presence of 
heterocyclic analog 4-{(E)-[(phenyl) methylidene] amino}-N-(Pyrimidin-
2yl) benzene-1-sulfonamide moiety with its structure. On docking study 
results, it was quite understood that all the basic analog of this proposed 
molecules showed a best target-protein interaction through hydrogen 
bond acceptor, hydrogen bond donor, side chain acceptor, and side 
chain donor atoms/groups present in this molecules. Consequently, it is 
important to highlight that these atoms could also participate in arene-
arene interactions with some receptor amino acid residues. Hence, 
according to the present study, it can be suggested that the study of these 
nine sulfadiazine molecules could be the first step in the development of 
novel agent which can act as an antimycobacterial drug.
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